Doctors Note Logo

Published on: 2/7/2026

Farxiga in Seniors: Benefits for Heart Failure & Kidneys

Farxiga can help many seniors with heart failure and chronic kidney disease by reducing hospitalizations and cardiovascular death and by slowing kidney decline, even for those without diabetes. There are several factors to consider, including side effects, when to pause it during illness or surgery, and how kidney function, blood pressure, and hydration guide safe use, so see below for important details that could shape your next steps with your clinician.

answer background

Explanation

Farxiga in Seniors: Benefits for Heart Failure & Kidneys

Farxiga (dapagliflozin) is a prescription medication originally developed to help lower blood sugar in people with type 2 diabetes. Over the past several years, strong clinical evidence has shown that Farxiga also offers important heart and kidney benefits, even for people without diabetes. These benefits are especially meaningful for older adults, who are more likely to live with heart failure or chronic kidney disease.

Below is a clear, balanced look at how Farxiga works, why it may help seniors, what the benefits are for the heart and kidneys, and what risks should be considered.


What Is Farxiga and How Does It Work?

Farxiga belongs to a class of medications called SGLT2 inhibitors. These drugs work by helping the kidneys remove excess glucose (sugar) and sodium through urine.

In simple terms, Farxiga:

  • Lowers blood sugar (if elevated)
  • Reduces extra fluid in the body
  • Decreases strain on the heart
  • Helps protect kidney function over time

This combination explains why Farxiga has become a key treatment not just for diabetes, but also for heart failure and chronic kidney disease (CKD).


Why Farxiga Matters for Seniors

As people age, the risks of:

  • Heart failure
  • Kidney disease
  • Hospitalizations
  • Medication side effects

all increase.

Farxiga is now widely used in older adults because it:

  • Has proven benefits beyond blood sugar control
  • Is taken once daily
  • Works independently of insulin
  • Has a generally predictable safety profile when monitored properly

Clinical trials such as DAPA-HF and DAPA-CKD included many adults over age 65, showing benefits across age groups, including seniors.


Farxiga and Heart Failure: Key Benefits

Heart failure occurs when the heart cannot pump blood efficiently. This can lead to fatigue, shortness of breath, and fluid buildup. Farxiga has been shown to help in both major types of heart failure:

  • Heart failure with reduced ejection fraction (HFrEF)
  • Heart failure with preserved ejection fraction (HFpEF)

Benefits for the Heart

Studies show that Farxiga can:

  • Reduce hospitalizations for heart failure
  • Lower the risk of cardiovascular death
  • Improve symptoms like swelling and breathlessness
  • Help patients stay more active and independent

These benefits occur whether or not a person has diabetes.

Why This Is Important for Seniors

For older adults, avoiding hospital stays can:

  • Preserve independence
  • Reduce complications like infections or confusion
  • Improve overall quality of life

Farxiga helps by gently reducing excess fluid and easing the workload on the heart.


Farxiga and Kidney Protection

Kidney function naturally declines with age. Conditions like diabetes, high blood pressure, and heart disease can speed this up.

Farxiga is now approved to help slow kidney disease progression in people with chronic kidney disease, including those without diabetes.

Kidney Benefits Include:

  • Slowing the decline in kidney function (eGFR)
  • Reducing the risk of kidney failure
  • Lowering the need for dialysis or transplant
  • Reducing death related to kidney or heart disease

How Farxiga Helps the Kidneys

Farxiga:

  • Reduces pressure inside kidney filtering units
  • Improves blood flow dynamics in the kidneys
  • Lowers inflammation and scarring over time

For seniors, this can mean more years of stable kidney function.


Dosage and Use in Older Adults

  • Typical dose: 10 mg once daily
  • Taken with or without food
  • Often used alongside other heart or kidney medications

Farxiga is generally started when kidney function (eGFR) is 25 or higher, depending on the condition being treated.

Because seniors may take multiple medications, doctors usually review:

  • Kidney function
  • Blood pressure
  • Fluid status

before and after starting Farxiga.


Possible Side Effects: What Seniors Should Know

Farxiga is well tolerated by many people, but no medication is risk-free.

Common or Manageable Side Effects

  • Increased urination
  • Mild dehydration
  • Genital yeast infections
  • Urinary tract infections
  • Dizziness when standing (especially early on)

Less Common but Serious Risks

  • Low blood pressure due to fluid loss
  • Diabetic ketoacidosis (rare, can occur even with normal blood sugar)
  • Kidney injury (uncommon, usually related to dehydration)
  • Severe genital infections (very rare)

These risks are uncommon, but seniors should be monitored closely—especially during illness, hot weather, or poor oral intake.

If symptoms like severe weakness, confusion, vomiting, or fainting occur, seek medical care immediately.


A Note on Excessive Thirst and Urination

Because Farxiga increases urination, some people may notice:

  • Persistent thirst
  • Large amounts of urine
  • Frequent nighttime urination

In rare cases, these symptoms may overlap with a completely different condition that affects the body's ability to regulate water balance. If you're experiencing unexplained excessive thirst and urination that seems unusual or unrelated to your medication, you can use a free symptom checker for Diabetes Insipidus to explore whether your symptoms might be connected to this rare condition and help prepare questions for your doctor.


Who Should Be Cautious or Avoid Farxiga?

Farxiga may not be appropriate for everyone. Extra caution is needed if you:

  • Have frequent dehydration
  • Have very low blood pressure
  • Are prone to recurrent infections
  • Have type 1 diabetes
  • Are scheduled for major surgery
  • Are unable to maintain adequate fluid intake

Your doctor may temporarily stop Farxiga during acute illness or before surgery to reduce risk.


Final Thoughts: Is Farxiga Right for You?

For many seniors, Farxiga offers meaningful protection for the heart and kidneys, helping reduce hospital stays and slow disease progression. Its benefits go beyond blood sugar control and extend to people with and without diabetes.

That said, individual health matters. Age, kidney function, other medications, and overall health all play a role in deciding if Farxiga is appropriate.

Key Takeaways

  • Farxiga helps protect the heart and kidneys
  • Benefits apply to seniors, even without diabetes
  • Side effects are usually manageable with proper monitoring
  • Staying hydrated and informed is essential

If you or a loved one is considering Farxiga—or already taking it—speak to a doctor about any symptoms, side effects, or concerns. This is especially important if anything feels serious or life-threatening. Open, ongoing communication with a healthcare professional is the safest way to get the full benefits while minimizing risks.

(References)

  • * Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Chaudhry GM, et al. Age and effect of dapagliflozin in heart failure with preserved ejection fraction in DELIVER trial. Eur Heart J. 2023 Mar 1;44(9):788-798.

  • * Wheeler DC, Stefánsson BV, Jongs N, Chertow GM, Claggett B, Greene SJ, et al. Efficacy and safety of dapagliflozin in older versus younger patients with chronic kidney disease: a prespecified subgroup analysis of the DAPA-CKD trial. Lancet Healthy Longev. 2023 Oct;4(10):e523-e532.

  • * Jhund PS, Abraham WT, Butler J, Desai AS, Filippatos G, Goyal P, et al. Efficacy and Safety of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction Across the Spectrum of Age: Insights From DAPA-HF. Circulation. 2022 May 31;145(22):1668-1681.

  • * Khazai NB, Williams K, Inman S, Kalayjian EJ, Kates M. SGLT2 inhibitors for heart failure and kidney disease: a focus on older adults. J Geriatr Cardiol. 2023 Apr 28;20(4):255-265.

  • * Baviera M, Manca P, De Luca M, Lapi F, Nardi R, Cammalleri V, et al. SGLT2 inhibitors in older adults: beyond glycaemic control. G Ital Cardiol (Rome). 2023 Aug;24(8):659-666.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Learn more about diseases

Diabetes Insipidus

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.